Lily Chu
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Lily Chu, MD, MSHS, is board certified in both internal medicine and geriatric medicine.[1]
Education[edit | edit source]
- Geriatric Medicine Fellowship, University of California, Los Angeles
- MSHS, Public Health, University of California, Los Angeles
- Internal Medicine Residency, University of Rochester
- MD, University of Washington
- BS, Biology, University of Washington[2]
Boards and Committees[edit | edit source]
- Community Advisory Board Member at Stanford University Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome Initiative[3]
- Co-Vice president of the International Association for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis[4]
- Panel member of the 2015 Institute of Medicine report: Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness[5]
ME/CFS Common Data Elements (CDE) Project[edit | edit source]
Dr Chu is Co-chair of Post-exertional Malaise Working Group and a member of the Sleep Working Group and the Biomarkers Working Group of the Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Common Data Elements (CDE) Project sponsored by the National Institute of Neurological Disorders and Stroke and the Centers for Disease Control and Prevention.[6]
Quotes[edit | edit source]
- 2016, "Ultimately the best way to prevent suicide in ME/CFS will be to find effective disease-modifying treatments or cures for it."[7]
Publications[edit | edit source]
- 2012, "Exercise and chronic fatigue syndrome: maximize function, minimize post-exertional malaise," Letter to the Editor, European Journal of Clinical Investigation[8]
- Preliminary Results – April 2013 FDA Workshop Survey, By Lily Chu, Leonard Jason, Madison Sunnquist, and Suzanna So
- May 2016, [http:http://iacfsme.org/PDFS/2016MayNesletter/Attachment-03-Dr-Lily-Chu-ME-CFS-and-suicide.aspx Suicide and ME/CFS -- Lily Chu, MD, MSHS]
- 2017, Article commentary - Differences of opinion on systemic exercise intolerance disease are not ‘mistakes’: a rejoinder to Jason Sunnquist, Gleason and Fox[9]
Open Letter to The Lancet[edit | edit source]
Three open letters to the editor of The Lancet have been sent urging the editor to commission a fully independent review of the PACE trial, which the journal had published in 2011. In 2016, Dr. Chu, along with 41 colleagues in the ME/CFS field, signed the second letter.
- 10 February 2016, An open letter to The Lancet, again - Virology blog
Notable studies[edit | edit source]
- 2021, Caring for the Patient with Severe or Very Severe Myalgic Encephalomyelitis/Chronic Fatigue Syndrome[10] - (Full text)
- 2021, Identifying and Managing Suicidality in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome[11] - (Full text)
- 2020, Environmental accommodations for university students affected by myalgic Encephalomyelitis/Chronic fatigue syndrome (ME/CFS)[12] - (Full text)
- 2019, Onset patterns and course of myalgic encephalomyelitis/chronic fatigue syndrome[13] - (Full text)
- 2018, Deconstructing post-exertional malaise in myalgic encephalomyelitis/ chronic fatigue syndrome: A patient-centered, cross-sectional survey[14] - (Full Text)
- 2017, Cytokine signature associated with disease severity in chronic fatigue syndrome patients[15] - (Full Text)
- 2017, Patients diagnosed with Myalgic encephalomyelitis/chronic fatigue syndrome also fit systemic exertion intolerance disease criteria[16]
- 2013, Daily cytokine fluctuations, driven by leptin, are associated with fatigue severity in chronic fatigue syndrome: Evidence of inflammatory pathology[17] - (Full Text)
Talks and interviews[edit | edit source]
HHS/CFSAC Testimony[edit | edit source]
- CFSAC Public Testimony December 2014
- Written Testimony for June 2012 meeting
- Written Testimony for Nov 2011 meeting
- Written Testimony for May 2011 meeting
- Written Testimony for October 2009 meeting
Online presence[edit | edit source]
- Youtube
- Website
Learn more[edit | edit source]
See also[edit | edit source]
References[edit | edit source]
- ↑ International Association for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis. "Lily Chu". Retrieved February 7, 2019.
- ↑ "Lily Chu". LinkedIn. Retrieved February 7, 2019.
- ↑ Stanford ME/CFS Initiative. "Meet the Team". ME/CFS Initiative. Retrieved February 7, 2019.
- ↑ International Association for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis. "Leadership of the IACFS". Retrieved February 7, 2019.
- ↑ Institute of Medicine (2015). Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness. Washington, DC: The National Academies Press. doi:10.17226/19012. ISBN 0309316898. PMID 25695122.
- ↑ "Complete Myalgic Encephalomyelitis/Chronic Fatigue Syndrome CDE Roster". NIH. Retrieved October 11, 2019.
- ↑ http:http://iacfsme.org/PDFS/2016MayNesletter/Attachment-03-Dr-Lily-Chu-ME-CFS-and-suicide.aspx
- ↑ Chu, Lily; Friedberg, Fred; Friedman, Kenneth J.; Littrell, Nereida; Stevens, Staci; Vallings, Ros (2012). "Exercise and chronic fatigue syndrome: maximize function, minimize post-exertional malaise". European Journal of Clinical Investigation. 42 (12): 1362–1362. doi:10.1111/j.1365-2362.2012.02723.x. ISSN 1365-2362.
- ↑ Chu, Lily; Valencia, Ian J.; Montoya, Jose G. (2017). "Differences of opinion on systemic exercise intolerance disease are not 'mistakes': a rejoinder to Jason Sunnquist, Gleason and Fox". Fatigue: Biomedicine, Health & Behavior. doi:10.1080/21641846.2017.1362750.
- ↑ Montoya, Jose; Dowell, Theresa; Mooney, Amy; Dimmock, Mary; Chu, Lily (October 6, 2021). "Caring for the Patient with Severe or Very Severe Myalgic Encephalomyelitis/Chronic Fatigue Syndrome". Healthcare. 9 (10): 1331. doi:10.3390/healthcare9101331. ISSN 2227-9032. PMC 8544443. PMID 34683011.
- ↑ Chu, Lily; Elliott, Meghan; Stein, Eleanor; Jason, Leonard A. "Managing Suicidality in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome". Healthcare. 9 (6): 629. doi:10.3390/healthcare9060629. ISSN 2227-9032. PMC 8227525. PMID 34070367.
- ↑ Chu, Lily; Fuentes, Lynn R.; Marshall, Olena M.; Mirin, Arthur A. (January 1, 2020). "Environmental accommodations for university students affected by Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)". Work. 66 (2): 315–326. doi:10.3233/WOR-203176. ISSN 1051-9815.
- ↑ Chu, Lily; Valencia, Ian J.; Garvert, Donn W.; Montoya, Jose G. (February 5, 2019). "Onset Patterns and Course of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome". Frontiers in Pediatrics. 7 (12). doi:10.3389/fped.2019.00012.
- ↑ Chu, Lily; Valencia, Ian J.; Garvert, Donn W.; Montoya, Jose G. (June 1, 2018). "Deconstructing post-exertional malaise in myalgic encephalomyelitis/ chronic fatigue syndrome: A patient-centered, cross-sectional survey". PLOS One. 13 (1): e0197811. doi:10.1371/journal.pone.0197811.
- ↑ Montoya, Jose G.; Holmes, Tyson H.; Anderson, Jill N.; Maecker, Holden T.; Rosenberg-Hasson, Yael; Valencia, Ian J.; Chu, Lily; Younger, Jarred W.; Tato, Cristina M.; Davis, Mark M. (2017). "Cytokine signature associated with disease severity in chronic fatigue syndrome patients". Proceedings of the National Academy of Sciences of the United States of America. 114 (34): E7150-E7158. doi:10.1073/pnas.1710519114.
- ↑ Chu, Lily; Norris, Jane; Valencia, Ian J.; Montoya, Jose G. (2017). "Patients diagnosed with Myalgic encephalomyelitis/chronic fatigue syndrome also fit systemic exertion intolerance disease criteria". Fatigue: Biomedicine, Health & Behavior. 5. doi:10.1080/21641846.2017.1299079.
- ↑ Stringer, EA; Baker, KS; Carrol, IR; Montoya, JG; Chu, L; Maeker, HT; Younger, JW (April 9, 2013). "Daily cytokine fluctuations, driven by leptin, are associated with fatigue severity in chronic fatigue syndrome: Evidence of inflammatory pathology,". J Transl Med. doi:10.1186/1479-5876-11-93. PMID 23570606.
